Yahoo Web Search

  1. Yahoo Finance Results

  2. The much followed and widely speculated entry by Amazon.com, Inc. AMZN into pharmacy business has now been put to rest with the company’s announcing that it will purchase PillPack, an online ...

  3. Pot businesses urge California to delay strict testing rules

    Associated Press via Yahoo FinanceJun 29 23:16 PM

    Jerry Brown, the United Cannabis Business Association said the changes would further unsettle the struggling legal marketplace that launched Jan. 1, potentially forcing businesses to ...

  4. Mitral valve regurgitation occurs when blood flows backward through the mitral valve and into the atrium each time the left ventricle contracts because the mitral valve doesn't close ...

  5. The Man & Woman of the Year candidates are compassionate and relentless in their desire to find cures for blood cancers and driven to reach their own personal fundraising best. This year's ...

  6. John Greene, senior vice president, Salesforce.com, Inc. and a blood cancer survivor, also joined the LLS Board.

  7. 10 Small-Caps Leading the Market Rebound

    InvestorPlace via Yahoo FinanceJul 10 13:19 PM

    The company has benefitted from a strong housing market and remodeling demand. The company will next report results on July 30 after the close. Analysts are looking for earnings of 65 cents ...

  8. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high ...

  9. There are now more than 75,000 genetic tests. The global genetic testing market is expected to surpass $22 billion by 2024, according to consulting firm Global Market Insights. Because some ...

  10. ROCKVILLE, Md., July 11, 2018 /PRNewswire-USNewswire/ -- Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full ...

  11. The National Kidney Foundation (NKF) is pleased that CMS has included key issues that we, and the patients we represent, have spoken out on for many years such as lack of innovation in therapies ...